MY177804A - Hcv polymerase inhibitors - Google Patents
Hcv polymerase inhibitorsInfo
- Publication number
- MY177804A MY177804A MYPI2016700722A MYPI2016700722A MY177804A MY 177804 A MY177804 A MY 177804A MY PI2016700722 A MYPI2016700722 A MY PI2016700722A MY PI2016700722 A MYPI2016700722 A MY PI2016700722A MY 177804 A MY177804 A MY 177804A
- Authority
- MY
- Malaysia
- Prior art keywords
- hcv polymerase
- polymerase inhibitors
- prophylaxis
- hepatitis
- variables
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/11—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/213—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE1351026 | 2013-09-04 | ||
SE1351169 | 2013-10-03 | ||
SE1450152 | 2014-02-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY177804A true MY177804A (en) | 2020-09-23 |
Family
ID=52628746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2016700722A MY177804A (en) | 2013-09-04 | 2014-09-02 | Hcv polymerase inhibitors |
Country Status (29)
Country | Link |
---|---|
US (5) | US9481703B2 (fr) |
EP (2) | EP3252066B1 (fr) |
JP (2) | JP6456958B2 (fr) |
KR (1) | KR20160078337A (fr) |
CN (3) | CN108676047B (fr) |
AU (2) | AU2014315715B2 (fr) |
BR (1) | BR112016004919A2 (fr) |
CA (1) | CA2921899A1 (fr) |
CL (2) | CL2016000493A1 (fr) |
CR (1) | CR20160123A (fr) |
CY (1) | CY1119587T1 (fr) |
DK (1) | DK3041855T3 (fr) |
EA (1) | EA028974B1 (fr) |
HK (2) | HK1221228A1 (fr) |
HR (1) | HRP20171435T1 (fr) |
HU (1) | HUE036365T2 (fr) |
IL (2) | IL244389B (fr) |
ME (1) | ME02875B (fr) |
MX (1) | MX2016002849A (fr) |
MY (1) | MY177804A (fr) |
PH (2) | PH12016500402A1 (fr) |
PL (1) | PL3041855T3 (fr) |
PT (1) | PT3041855T (fr) |
RS (1) | RS56383B1 (fr) |
SA (1) | SA516370684B1 (fr) |
SG (2) | SG10201700647PA (fr) |
SI (1) | SI3041855T1 (fr) |
UA (1) | UA117375C2 (fr) |
WO (1) | WO2015034420A1 (fr) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010295392B2 (en) | 2009-09-21 | 2015-10-22 | Gilead Sciences, Inc. | Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs |
BR122020020745B8 (pt) | 2010-07-22 | 2023-10-31 | Gilead Sciences Inc | Composto antiviral para o tratamento de infecções por paramyxoviridae e composição farmacêutica que o compreende |
CN104151360B (zh) * | 2013-05-14 | 2019-02-22 | 北京美倍他药物研究有限公司 | 磷酸/膦酸衍生物及其医药用途 |
UA117375C2 (uk) | 2013-09-04 | 2018-07-25 | Медівір Аб | Інгібітори полімерази hcv |
EP3074411A2 (fr) | 2013-11-27 | 2016-10-05 | Idenix Pharmaceuticals LLC | Nucléotides pour le traitement du cancer du foie |
US20170198005A1 (en) * | 2013-11-27 | 2017-07-13 | Idenix Pharmaceuticals Llc | 2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection |
CA2946867C (fr) * | 2014-04-24 | 2023-03-07 | Cocrystal Pharma, Inc. | Analogues de nucleosides disubstitues en 2' pour le traitement des virus de la famille des flaviviridae et du cancer |
CN105315319B (zh) * | 2014-07-30 | 2020-11-20 | 南京圣和药业股份有限公司 | 丙型肝炎病毒抑制剂及其应用 |
TWI687432B (zh) * | 2014-10-29 | 2020-03-11 | 美商基利科學股份有限公司 | 絲狀病毒科病毒感染之治療 |
RU2687160C2 (ru) * | 2014-12-30 | 2019-05-07 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Пиколинамидные соединения с фунгицидной активностью |
EP3240419B1 (fr) | 2014-12-30 | 2020-05-06 | Dow Agrosciences LLC | Composés de picolinamide présentant une activité fongicide |
RU2702088C2 (ru) | 2014-12-30 | 2019-10-03 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Применение соединений пиколинамида в качестве фунгицидов |
RU2703402C2 (ru) | 2014-12-30 | 2019-10-16 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Пиколинамиды с фунгицидной активностью |
WO2016134057A1 (fr) * | 2015-02-18 | 2016-08-25 | Abbvie Inc. | Composés anti-viraux |
EA201791848A1 (ru) * | 2015-03-02 | 2018-03-30 | Медивир Аб | Композиция фосфорамидата нуклеотида |
EP3271371A4 (fr) * | 2015-03-02 | 2018-12-05 | Medivir Aktiebolag | Dérivés nucléotidiques qui sont des inhibiteurs du vhc pour une utilisation dans le traitement de l'hépatite c |
WO2016160646A1 (fr) * | 2015-04-02 | 2016-10-06 | Merck Sharp & Dohme Corp. | Procédé de fabrication de composés de nucléoside protégés par un phosphoramidate |
EP3288957A4 (fr) * | 2015-05-01 | 2019-01-23 | Cocrystal Pharma, Inc. | Analogues de nucléosides à utiliser pour le traitement d'infections par des virus de la famille des flaviviridae et du cancer |
WO2017040896A1 (fr) * | 2015-09-02 | 2017-03-09 | Abbvie Inc. | Composés anti-viraux |
CN108350016B (zh) * | 2015-09-02 | 2021-07-27 | 艾伯维公司 | 抗病毒四氢呋喃衍生物 |
WO2017040898A1 (fr) * | 2015-09-02 | 2017-03-09 | Abbvie Inc. | Composés anti-viraux |
WO2017040889A1 (fr) * | 2015-09-02 | 2017-03-09 | Abbvie Inc. | Composés anti-viraux |
WO2017040892A1 (fr) * | 2015-09-02 | 2017-03-09 | Abbvie Inc. | Composés anti-viraux |
WO2017040895A1 (fr) * | 2015-09-02 | 2017-03-09 | Abbvie Inc. | Composés anti-viraux |
JP6742403B2 (ja) | 2015-09-16 | 2020-08-19 | ギリアード サイエンシーズ, インコーポレイテッド | アレナウイルス科およびコロナウイルス科のウイルス感染を処置するための方法 |
CN105367505A (zh) * | 2015-12-01 | 2016-03-02 | 苏利制药科技江阴有限公司 | 一种新型合成3,6-二甲基-2,5-哌嗪二酮的方法 |
WO2018033593A1 (fr) * | 2016-08-19 | 2018-02-22 | Sandoz Ag | Dérivés de sofosbuvir pour le traitement de l'hépatite c |
KR102460968B1 (ko) | 2017-03-14 | 2022-11-01 | 길리애드 사이언시즈, 인코포레이티드 | 고양이 코로나바이러스 감염의 치료 방법 |
AR111490A1 (es) | 2017-05-01 | 2019-07-17 | Gilead Sciences Inc | Formas cristalinas de propanoato de (s)-2-etilbutil 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopirrolo[2,1-f][1,2,4]triazin-7-il)-5-ciano-3,4-dihidroxitetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino) |
CA3062074A1 (fr) | 2017-05-02 | 2018-11-08 | Dow Agrosciences Llc | Utilisation d'un compose picolinamide acyclique en tant que fongicide pour lutter contre des maladies fongiques sur des gazons |
TWI774761B (zh) | 2017-05-02 | 2022-08-21 | 美商科迪華農業科技有限責任公司 | 用於穀物中的真菌防治之協同性混合物 |
TW201842851A (zh) | 2017-05-02 | 2018-12-16 | 美商陶氏農業科學公司 | 用於穀類中的真菌防治之協同性混合物 |
EP3651734A1 (fr) | 2017-07-11 | 2020-05-20 | Gilead Sciences, Inc. | Compositions comprenant un inhibiteur d'arn polymérase et de la cyclodextrine pour le traitement d'infections virales |
WO2019018185A1 (fr) | 2017-07-15 | 2019-01-24 | Arisan Therapeutics Inc. | Dérivés énantiomériquement purs d'adamatane pour le traitement d'infections à filovirus |
BR102019004480B1 (pt) | 2018-03-08 | 2023-03-28 | Dow Agrosciences Llc | Picolinamidas como fungicidas |
CA3094958A1 (fr) | 2018-03-09 | 2019-09-12 | Medivir Aktiebolag | Traitement du cancer a l'aide de nucleotides de (2,2-bishydroxymethyl) methylenecyclopropane |
JP2022512697A (ja) | 2018-10-15 | 2022-02-07 | コルテバ アグリサイエンス エルエルシー | オキシピコリンアミドの合成のための方法 |
CN109762040A (zh) * | 2019-01-14 | 2019-05-17 | 歌礼生物制药(杭州)有限公司 | 一种核苷类ns5b聚合酶抑制剂的制备方法 |
TW202313067A (zh) | 2020-01-27 | 2023-04-01 | 美商基利科學股份有限公司 | 治療sars cov-2感染之方法 |
US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
CN111269263A (zh) * | 2020-03-09 | 2020-06-12 | 上海龙翔生物医药开发有限公司 | 一种瑞德西韦侧链中间体及其制备方法 |
EP4118085A2 (fr) | 2020-03-12 | 2023-01-18 | Gilead Sciences, Inc. | Procédés de préparation de 1 '-cyano nucléosides |
KR20220164784A (ko) | 2020-04-06 | 2022-12-13 | 길리애드 사이언시즈, 인코포레이티드 | 1'-시아노 치환된 카르바뉴클레오시드 유사체의 흡입 제형 |
CN111848679A (zh) * | 2020-04-17 | 2020-10-30 | 山东科巢生物制药有限公司 | 一种利用微通道反应技术合成瑞德西韦的方法 |
TW202203941A (zh) | 2020-05-29 | 2022-02-01 | 美商基利科學股份有限公司 | 瑞德西韋之治療方法 |
AU2021296841A1 (en) | 2020-06-24 | 2023-02-16 | Gilead Sciences, Inc. | 1'-cyano nucleoside analogs and uses thereof |
DK4204421T3 (da) | 2020-08-27 | 2024-05-27 | Gilead Sciences Inc | Forbindelser og fremgangsmåder til behandling af virale infektioner |
TW202400185A (zh) | 2022-03-02 | 2024-01-01 | 美商基利科學股份有限公司 | 用於治療病毒感染的化合物及方法 |
CN116199679A (zh) * | 2022-12-23 | 2023-06-02 | 吉斯凯(苏州)制药有限公司 | 一种拉米夫定的工业化制备方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2170020C (fr) | 1992-12-29 | 2005-08-02 | Dale J. Kempf | Composes inhibant la protease retrovirale |
IL110752A (en) | 1993-09-13 | 2000-07-26 | Abbott Lab | Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor |
US5559158A (en) | 1993-10-01 | 1996-09-24 | Abbott Laboratories | Pharmaceutical composition |
IL111991A (en) | 1994-01-28 | 2000-07-26 | Abbott Lab | Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent |
US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
PT1411954E (pt) * | 2000-10-18 | 2011-03-16 | Pharmasset Inc | Nucleosídeos modificados para o tratamento de infecções virais e proliferação celular anormal |
PE20070211A1 (es) | 2005-07-29 | 2007-05-12 | Medivir Ab | Compuestos macrociclicos como inhibidores del virus de hepatitis c |
US20090298708A1 (en) * | 2006-08-23 | 2009-12-03 | Masad Damha J | 2'-deoxy-2'-fluoro-beta-d-arabinonucleoside 5'-triphosphates and their use in enzymatic nucleic acid synthesis |
KR20090078347A (ko) * | 2006-10-10 | 2009-07-17 | 메디비르 아베 | Hcv 뉴클레오시드 억제제 |
US7951789B2 (en) | 2006-12-28 | 2011-05-31 | Idenix Pharmaceuticals, Inc. | Compounds and pharmaceutical compositions for the treatment of viral infections |
US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
EP2234623A4 (fr) | 2007-12-27 | 2012-03-28 | Epiphany Biosciences | Composés antiviraux |
US8173621B2 (en) * | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
BRPI0923815A2 (pt) | 2008-12-23 | 2015-07-14 | Pharmasset Inc | Síntese de nucleosídeos de purina |
AU2010226466A1 (en) * | 2009-03-20 | 2011-10-20 | Alios Biopharma, Inc. | Substituted nucleoside and nucleotide analogs |
CN101591371B (zh) * | 2009-06-30 | 2012-05-30 | 连云港金康医药科技有限公司 | 一种通过卤交换氟化制备吉西他滨或其类似物的方法 |
EP2609923B1 (fr) | 2010-03-31 | 2017-05-24 | Gilead Pharmasset LLC | Procede de crystallisation de (s)-isopropyl 2-(((s)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
US8402690B2 (en) | 2010-09-09 | 2013-03-26 | Sterling International Inc. | Bedbug trap |
US20120070411A1 (en) * | 2010-09-22 | 2012-03-22 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
CA2810928A1 (fr) * | 2010-09-22 | 2012-03-29 | Alios Biopharma, Inc. | Analogues nucleotidiques substitues |
SG194485A1 (en) | 2011-04-13 | 2013-12-30 | Merck Sharp & Dohme | 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
WO2013039920A1 (fr) | 2011-09-12 | 2013-03-21 | Idenix Pharmaceuticals, Inc. | Composés de carbonyloxyméthylphosphoramidate substitué et compositions pharmaceutiques servant à traiter les infections virales |
EP3466959A1 (fr) | 2011-12-22 | 2019-04-10 | Janssen BioPharma, Inc. | Nucléosides substitués, nucléotides et leurs analogues |
WO2014078427A1 (fr) | 2012-11-14 | 2014-05-22 | Idenix Pharmaceuticals, Inc. | Ester de d-alanine d'analogue de rp-nucléoside |
UA117375C2 (uk) * | 2013-09-04 | 2018-07-25 | Медівір Аб | Інгібітори полімерази hcv |
EP3074411A2 (fr) * | 2013-11-27 | 2016-10-05 | Idenix Pharmaceuticals LLC | Nucléotides pour le traitement du cancer du foie |
US20170198005A1 (en) * | 2013-11-27 | 2017-07-13 | Idenix Pharmaceuticals Llc | 2'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infection |
CA2946867C (fr) | 2014-04-24 | 2023-03-07 | Cocrystal Pharma, Inc. | Analogues de nucleosides disubstitues en 2' pour le traitement des virus de la famille des flaviviridae et du cancer |
-
2014
- 2014-02-09 UA UAA201602085A patent/UA117375C2/uk unknown
- 2014-09-02 EP EP17176973.0A patent/EP3252066B1/fr active Active
- 2014-09-02 AU AU2014315715A patent/AU2014315715B2/en not_active Ceased
- 2014-09-02 SG SG10201700647PA patent/SG10201700647PA/en unknown
- 2014-09-02 CN CN201810472644.9A patent/CN108676047B/zh active Active
- 2014-09-02 ME MEP-2017-229A patent/ME02875B/fr unknown
- 2014-09-02 JP JP2016540848A patent/JP6456958B2/ja active Active
- 2014-09-02 SG SG11201601474UA patent/SG11201601474UA/en unknown
- 2014-09-02 DK DK14789434.9T patent/DK3041855T3/en active
- 2014-09-02 RS RS20170949A patent/RS56383B1/sr unknown
- 2014-09-02 CN CN201810473163.XA patent/CN108558973A/zh active Pending
- 2014-09-02 CN CN201480060874.4A patent/CN105705510B/zh active Active
- 2014-09-02 PT PT147894349T patent/PT3041855T/pt unknown
- 2014-09-02 EA EA201690452A patent/EA028974B1/ru not_active IP Right Cessation
- 2014-09-02 HU HUE14789434A patent/HUE036365T2/hu unknown
- 2014-09-02 CA CA2921899A patent/CA2921899A1/fr not_active Abandoned
- 2014-09-02 PL PL14789434T patent/PL3041855T3/pl unknown
- 2014-09-02 EP EP14789434.9A patent/EP3041855B1/fr active Active
- 2014-09-02 KR KR1020167008381A patent/KR20160078337A/ko not_active Application Discontinuation
- 2014-09-02 WO PCT/SE2014/051005 patent/WO2015034420A1/fr active Application Filing
- 2014-09-02 SI SI201430401T patent/SI3041855T1/sl unknown
- 2014-09-02 MX MX2016002849A patent/MX2016002849A/es unknown
- 2014-09-02 MY MYPI2016700722A patent/MY177804A/en unknown
- 2014-09-02 BR BR112016004919A patent/BR112016004919A2/pt not_active Application Discontinuation
-
2015
- 2015-02-27 US US14/634,449 patent/US9481703B2/en active Active
-
2016
- 2016-02-29 PH PH12016500402A patent/PH12016500402A1/en unknown
- 2016-03-02 IL IL244389A patent/IL244389B/en not_active IP Right Cessation
- 2016-03-03 CL CL2016000493A patent/CL2016000493A1/es unknown
- 2016-03-06 SA SA516370684A patent/SA516370684B1/ar unknown
- 2016-03-10 CR CR20160123A patent/CR20160123A/es unknown
- 2016-07-14 US US15/210,500 patent/US9540411B2/en not_active Expired - Fee Related
- 2016-08-04 HK HK16109322.2A patent/HK1221228A1/zh unknown
- 2016-11-23 US US15/360,360 patent/US9828408B2/en not_active Expired - Fee Related
-
2017
- 2017-06-13 AU AU2017203954A patent/AU2017203954B2/en not_active Ceased
- 2017-09-25 HR HRP20171435TT patent/HRP20171435T1/hr unknown
- 2017-10-04 CY CY20171101032T patent/CY1119587T1/el unknown
- 2017-11-27 US US15/823,224 patent/US10106571B2/en not_active Expired - Fee Related
-
2018
- 2018-05-02 PH PH12018500931A patent/PH12018500931A1/en unknown
- 2018-09-12 IL IL261702A patent/IL261702B/en not_active IP Right Cessation
- 2018-10-12 JP JP2018193251A patent/JP2019065011A/ja not_active Ceased
- 2018-10-22 US US16/166,578 patent/US20190085010A1/en not_active Abandoned
- 2018-11-22 HK HK18114953.6A patent/HK1255872A1/zh unknown
-
2019
- 2019-02-01 CL CL2019000271A patent/CL2019000271A1/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500931A1 (en) | Hcv polymerase inhibitors | |
PH12016501254A1 (en) | Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection | |
MY188114A (en) | Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
PH12016500660A1 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
MX2017008720A (es) | Derivados y metodos para tratamiento de las infecciones por hepatitis b. | |
PH12017500207B1 (en) | Indoles for use in influenza virus infection | |
EA201690979A1 (ru) | Производные азепана и способы лечения инфекций гепатита в | |
PH12015500347A1 (en) | 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
MX2016013689A (es) | Compuestos 4-amino-imidazoquinolina. | |
MX2016009449A (es) | Terapia de combinacion para el tratamiento de infecciones por virus de la hepatitis b (vhb). | |
PH12017500393A1 (en) | Pyrrolopyrimidines for use in influenza virus infection | |
MX2015011193A (es) | Compuestos antivirales. | |
MX2017000312A (es) | Derivados de isoindolina para usarse en el tratamiento de una infeccion viral. | |
MX354676B (es) | Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv). | |
MX2016001855A (es) | Nuevos aza-oxo-indoles para el tratamiento y profilaxis de la infeccion por virus sincitial respiratorio. | |
MX2015011198A (es) | Compuestos antivirales. | |
WO2014123795A3 (fr) | Composés hétérocycliques tétracycliques et leurs procédés d'utilisation pour le traitement de l'hépatite c | |
MX2015009176A (es) | Derivados de triazola antivirales. | |
NZ726343A (en) | Antiviral compounds | |
MX2015010892A (es) | Compuestos antivirales. | |
MX2016001858A (es) | Aza-oxo-indoles novedosos para el tratamiento y profilaxis de la infeccion por el virus sincicial respiratorio. | |
MX2015011125A (es) | Compuestos antivirales. | |
MX2015011126A (es) | Compuestos antivirales. | |
MX2016009250A (es) | Nuevos imidazoles para el tratamiento y profilaxis de la infeccion por virus sincicial respiratorio. | |
MY163245A (en) | Hepatitis c virus inhibitors |